Table 3.
Ref. | Trials included (n) | Laparoscopic/open procedures (n) | TumOR = characteristics | Operative time (min) (WMD) | Blood loss (mL) (WMD) | Harvested lymph nodes (WMD) | Length-of-stay (WMD) | Complication rates | Mortality |
Memon et al[62], 2008 | 4 RCT’s | 82/80 | EGC, GC | +83 (P < 0.001) | -104 (P = 0.02) | -4.3 (P < 0.001) | -3.3 d (P = 0.14) | OR = 0.66 (P = 0.14) | OR = 0.94 (P = 0.94) |
Chen et al[60], 2009 | 6 RCT’s | 323/306 | EGC | +87 (P < 0.001) | -108 (P = 0.001) | -4.9 (P < 0.001) | -2.0 d (P = 0.14) | RR = 0.61 (P = 0.01) | Risk difference 0.01 (P = 0.32) |
Kodera et al[61], 2010 | 6 RCT’s | 343/323 | EGC, GC | +82 (P < 0.001) | -118 (P < 0.001) | -4.8 (P < 0.001) | NA | OR = 0.46 (P = 0.003) | OR = 0.17 (P = 0.86) |
Ohtani et al[63], 2011 | 5 RCT’s | 164/162 | EGC, GC | +82 (P < 0.001) | -122 (P < 0.001) | -4.8 (P < 0.001) | -2.5 d (P = 0.04) | OR = 0.38 (P = 0.01) | OR = 0.47 (P = 0.54) |
Viñuela et al[59], 2012 | 6 RCT’s | 1658/1397 | ECG, GC | +48.3 (P < 0.001) | -118 (P < 0.001) | -3.9 (P < 0.001) | -3.6 (P < 0.001) | OR = 0.59 (P < 0.001) | OR = 0.64 (P = 0.39) |
19 NRCT’s |
RCT: Randomized controlled trial; NRCT: Non-randomized controlled trial; EGC: Early gastric cancer; GC: Gastric cancer (all stages); WMD: Weighted mean difference; NA: Not available.